DoctoratClosing soon

PhD position: Targeted Radioenhancing Nanoparticles for Neuroblastoma (P2602)

EURAXESS hosting organisation · Plusieurs pays européens

This PhD project develops ultrasmall, intravenously deliverable hafnium oxide nanoparticles to improve radiotherapy for high-risk neuroblastoma, a pediatric cancer with poor prognosis and limited treatment options. Neuroblastoma remains a major unmet clinical need because high-risk disease is still associated with poor outcomes despite multimodal treatment, while conventional radio-chemotherapy is constrained by toxicity to healthy tissue. Radiotherapy-enhancing nanoparticles offer a promising route to increase local tumor damage without simply escalating X-ray dose. Hafnium oxide nanoparticles are attractive radioenhancers because hafnium strongly absorbs X-rays, leading to enhanced local energy deposition and free-radical generation during irradiation. Clinical studies have already demon

At a glance

Where: Multiple European countries
Deadline: 2026-09-25
Funding: Funding described on programme page
Board: EURAXESS

Who can apply

Criteria stated by the funder on the official source.

Nationality

EURAXESS vacancies rarely print a nationality table. Confirm whether applicants from Tunisia can apply and whether a residence/work permit pathway exists on the employer page.

Non indiqué

Education

Research Field Biological sciences Years of Research Experience 1 - 4 Research Field Chemistry Years of Research Experience 1 - 4 Research Field Chemistry Years of Research Experience 1 - 4

Non indiqué

Funding and what it does not cover

Funding details were taken from the official programme page text. Confirm the current call before applying.